Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ

We would like to respond to the Letter to the Editor of Bene et al. discussing our articles on the evaluation of the serological response 3 months after BNT162b2 vaccination.(1-3) The authors pointed out that we used a “catchy label” when referring to the observe decline of antibody titers. The authors added that our analysis can be “in this touchy context, (be) interpreted as bad news” and (they) “would like to re-interpret these data in a more positive way by emphasizing the high antibody titers detect ed in this study”.
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: Letter to the Editor Source Type: research